SINGEL STINA

Track

Insider profile

SINGEL STINA's trades of Ascendis Pharma A/S's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
400.71
Quantity 20,131
Value US$1,377,217
Transaction date
Proposed sale
Price
50.57
Quantity 37,515
Value US$1,034,595
Transaction date
Proposed sale
Price
458.50
Quantity 90,408
Value US$3,687,759
Transaction date
Proposed sale
Price
155.20
Quantity 2,729
Value US$423,542
Transaction date
Proposed sale
Price
129.13
Quantity 2,119
Value US$273,621
Transaction date
Proposed sale
Price
150.00
Quantity 6,900
Value US$1,035,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-09 2026-03-09
PrS Proposed sale
20,131
400.71
US$1,377,217 		20,131 400.71 US$1,377,217
2025-12-01 2025-12-01
PrS Proposed sale
37,515
50.57
US$1,034,595 		37,515 50.57 US$1,034,595
2025-03-04 2025-03-04
PrS Proposed sale
90,408
458.50
US$3,687,759 		90,408 458.50 US$3,687,759
2025-02-21 2025-02-20
PrS Proposed sale
2,729
155.20
US$423,542 		2,729 155.20 US$423,542
2024-12-10 2024-12-10
PrS Proposed sale
2,119
129.13
US$273,621 		2,119 129.13 US$273,621
2024-03-04 2024-03-01
PrS Proposed sale
6,900
150.00
US$1,035,000 		6,900 150.00 US$1,035,000